Thompson Oncology Group-Oak Ridge — Oak Ridge, Tennessee

Thompson Oncology Group-Oak Ridge is a clinical research site located in Oak Ridge, Tennessee, United States 37830.

Crixeo Clinical Trials Trust Score: 17/100 (FAILING). This profile has not yet been claimed by the site owner.

Thompson Oncology Group-Oak Ridge has participated in 9 clinical trials with 4 currently active.

Therapeutic areas: Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7, Breast Cancer.

Sponsors: SWOG Cancer Research Network, Alliance for Clinical Trials in Oncology, National Cancer Institute (NCI).

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Oak Ridge

Browse all research sites in Tennessee · View every site in Oak Ridge

Sponsor Feasibility Report

Trust Score: 17/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Thompson Oncology Group-Oak Ridge?

Thompson Oncology Group-Oak Ridge has a Crixeo Trust Score of 17/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Thompson Oncology Group-Oak Ridge conducted?

Thompson Oncology Group-Oak Ridge has 9 clinical trials on record, with 4 currently active. Their work covers Recurrent Squamous Cell Lung Carcinoma, Stage IV Squamous Cell Lung Carcinoma AJCC v7, Breast Cancer.

Is Thompson Oncology Group-Oak Ridge accredited by Crixeo Clinical Trials?

Thompson Oncology Group-Oak Ridge has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Thompson Oncology Group-Oak Ridge?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.